Zhi‐Ling Li

2.1k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

Zhi‐Ling Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhi‐Ling Li has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Zhi‐Ling Li's work include Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Zhi‐Ling Li is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Zhi‐Ling Li collaborates with scholars based in China and Mexico. Zhi‐Ling Li's co-authors include Rong Deng, Yun Huang, Gong‐Kan Feng, Xiao‐Feng Zhu, Yuhong Chen, Xiao-Dan Peng, Bingxin Hu, Tian Du, Hai‐Liang Zhang and Jia Mai and has published in prestigious journals such as Nature Communications, Nature Cell Biology and Cancer Research.

In The Last Decade

Zhi‐Ling Li

36 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis

2022 394 citations Hai‐Liang Zhang, Bingxin Hu et al. Nature Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhi‐Ling Li China	16	859	485	468	341	250	40	1.4k
Ting Wei China	24	946 1.1×	540 1.1×	338 0.7×	529 1.6×	271 1.1×	55	1.6k
Xiaowu Xu China	23	1.0k 1.2×	629 1.3×	393 0.8×	531 1.6×	176 0.7×	82	1.7k
Chaoyun Pan China	19	1.0k 1.2×	668 1.4×	223 0.5×	272 0.8×	242 1.0×	29	1.5k
Huichan He China	26	1.1k 1.3×	623 1.3×	384 0.8×	384 1.1×	176 0.7×	79	1.7k
Mark D. Long United States	21	778 0.9×	358 0.7×	254 0.5×	423 1.2×	288 1.2×	70	1.4k
Shan Rao China	11	872 1.0×	668 1.4×	197 0.4×	291 0.9×	311 1.2×	19	1.4k
Pin Yi China	11	797 0.9×	606 1.2×	190 0.4×	258 0.8×	290 1.2×	14	1.3k
Kwang‐Yu Chang Taiwan	21	772 0.9×	393 0.8×	207 0.4×	328 1.0×	137 0.5×	58	1.3k
Kaisa Cui China	21	864 1.0×	532 1.1×	141 0.3×	257 0.8×	279 1.1×	37	1.2k
Chuanyuan Wei China	19	1.1k 1.3×	729 1.5×	241 0.5×	343 1.0×	261 1.0×	52	1.6k

Countries citing papers authored by Zhi‐Ling Li

Since Specialization

Citations

This map shows the geographic impact of Zhi‐Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Ling Li more than expected).

Fields of papers citing papers by Zhi‐Ling Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Ling Li. The network helps show where Zhi‐Ling Li may publish in the future.

Co-authorship network of co-authors of Zhi‐Ling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Ling Li. A scholar is included among the top collaborators of Zhi‐Ling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Ling Li. Zhi‐Ling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaoyan, Xun Jiang, Ying Wang, et al.. (2025). Gastrointestinal complications of hepatic glycogen storage disease: a national survey questionnaire study in China. Orphanet Journal of Rare Diseases. 20(1). 41–41.

Shan, Jia‐Lu, Zhi‐Ling Li, Yun Huang, et al.. (2025). Reactivating cGAS–STING Signaling by Targeting SOS1 Enhances Antitumor Immunity in NRAS -Mutant Tumors. Cancer Research. 85(16). 3015–3031.

Yu, Feng, Mingyu Liu, Wenjing Zhang, et al.. (2025). Modulation of senescent Lepr+ skeletal stem cells via suppression of leptin-induced STAT3‒FGF7 axis activation alleviates abnormal subchondral bone remodeling and osteoarthritis progression. Stem Cell Research & Therapy. 16(1). 227–227. 2 indexed citations

Li, Zhi‐Ling, et al.. (2025). Clinical characteristics of active tuberculosis with pulmonary thromboembolism. BMC Pulmonary Medicine. 25(1). 156–156.

Li, Zhi‐Ling, et al.. (2024). Phase relationships of finite amplitude ultrasound waves and its application in determining nonlinear acoustical parameters. Applied Acoustics. 231. 110510–110510.

Zhang, Hai‐Liang, Bingxin Hu, Zhi‐Ling Li, et al.. (2024). TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer. Science Translational Medicine. 16(753). eadk0330–eadk0330. 32 indexed citations

Li, Xiang, Xiaoyan Zhang, Zhi‐Ling Li, et al.. (2024). GZMA suppressed GPX4-mediated ferroptosis to improve intestinal mucosal barrier function in inflammatory bowel disease. Cell Communication and Signaling. 22(1). 9 indexed citations

Yang, Dong, Mei-Han Duan, Zhi‐Ling Li, et al.. (2023). Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors. Journal of Translational Medicine. 21(1). 586–586. 4 indexed citations

Yang, Dong, Wei Wei, Qiaqia Li, et al.. (2023). Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer. International Journal of Biological Sciences. 19(6). 1846–1860. 11 indexed citations

10.

Li, Peilin, Dafu Chen, Xiaotong Li, et al.. (2023). Microgel-based carriers enhance skeletal stem cell reprogramming towards immunomodulatory phenotype in osteoarthritic therapy. Bioactive Materials. 34. 204–220. 15 indexed citations

11.

Zhang, Hai‐Liang, Bingxin Hu, Zhi‐Ling Li, et al.. (2022). PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nature Cell Biology. 24(1). 88–98. 394 indexed citations breakdown →

12.

Zhang, Kaiming, Tian Du, Gehao Liang, et al.. (2021). A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer. Frontiers in Molecular Biosciences. 8. 678877–678877. 63 indexed citations

13.

Ye, Zongbiao, Bo Chen, Jianjun Chen, et al.. (2021). Investigation into surface composition of nitrogen-doped niobium for superconducting RF cavities. Nanotechnology. 32(24). 245701–245701. 6 indexed citations

14.

Li, Zhi‐Ling, et al.. (2021). Innovative Strategies and Efforts of Clinical Pharmacy Services During and After COVID-19 Epidemic: Experience from Shanghai Children’s Hospital. Risk Management and Healthcare Policy. Volume 14. 4759–4764. 4 indexed citations

15.

Li, Peilin, Qian Wang, Wei Hu, et al.. (2021). Ferulic Acid Promotes Bone Defect Repair After Radiation by Maintaining the Stemness of Skeletal Stem Cells. Stem Cells Translational Medicine. 10(8). 1217–1231. 21 indexed citations

16.

Deng, Rong, Junhao Huang, Yan Wang, et al.. (2020). Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma. Molecular Cancer. 19(1). 122–122. 48 indexed citations

17.

Li, Zhi‐Ling, Hai‐Liang Zhang, Yun Huang, et al.. (2020). Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nature Communications. 11(1). 3806–3806. 136 indexed citations

18.

Wu, Rui-Yan, Pengfei Kong, Liang-Ping Xia, et al.. (2019). Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma. Clinical Cancer Research. 25(14). 4530–4541. 80 indexed citations

19.

Mai, Jia, Guifang Guo, Yan‐Qun Xiang, et al.. (2019). Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma. Theranostics. 9(12). 3541–3554. 30 indexed citations

20.

He, Qiu-ming, Lei Tan, Rui-Yan Wu, et al.. (2017). Overexpression of PTK6 predicts poor prognosis in bladder cancer patients. Journal of Cancer. 8(17). 3464–3473. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact